Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Drugs Aging. 2017 Dec;34(12):925–939. doi: 10.1007/s40266-017-0502-6

Table 4.

Univariable Associations

N=4730 ACB Sum 1–2 vs. 0 ACB Sum 3+ vs. 0 ACB Sum 3+ vs. 1–2

Variable OR (95% CI) Unadjusted OR (95% CI) Unadjusted OR (95% CI) Unadjusted

Predisposing Factors

Age (y) overall overall
 65–70 ref ref ref
 70–<80 0.72 (0.52, 1.00)* 0.75 (0.55, 1.03) 1.04 (0.77, 1.41)
 80–<90 0.82 (0.60, 1.11) 0.55 (0.40, 0.74) 0.67 (0.50, 0.89)
 90+ 0.75 (0.54, 1.02) 0.40 (0.29, 0.55) 0.54 (0.40, 0.73)

Sex
 Male ref ref ref
 Female 0.94 (0.80, 1.09) 1.08 (0.91, 1.27) 1.15 (0.98, 1.35)

Race/Ethnicity
 White(non-Hispanic) ref ref ref
 Black(non-Hispanic) 1.21 (0.92, 1.57) 1.14 (0.86, 1.51) 0.95 (0.72, 1.24)
 Hispanic 1.04 (0.75, 1.45) 0.94 (0.66, 1.33) 0.90 (0.63, 1.27)
 Other 0.95 (0.62, 1.46) 0.87 (0.55, 1.38) 0.92 (0.57, 1.47)

Medical Need Factors

Charlson Comorbidity Index overall overall overall
 0 or 1 ref ref ref
 2 or 3 1.25 (1.00, 1.55)* 1.60 (1.25, 2.05) 1.28 (0.99, 1.67)
 4 or 5 1.44 (1.16, 1.80) 2.15 (1.68, 2.75) 1.49 (1.15, 1.92)
 6+ 2.00 (1.63, 2.46) 2.84 (2.25, 3.59) 1.42 (1.12, 1.81)

Dementia Severity (as defined previously by: CCW diagnosis, CPS and functional status) overall overall overall
 Non-Dementia ref ref ref
 Dementia non-severe 0.85 (0.73, 0.98)* 1.31 (1.12, 1.53) 1.54 (1.32, 1.80)
 Dementia severe 0.64 (0.49, 0.84) 1.04 (0.79, 1.37) 1.62 (1.21, 2.18)

Use of Antidementia Medication overall overall overall
 AchEI only 125 (0.99, 1.57) 1.97 (1.58, 2.46) 1.58 (1.27, 1.96)
 Memantine only 1.51 (1.02, 2.24)* 1.90 (1.28, 2.84) 1.26 (0.87, 1.81)
 AchEI + Memantine 1.85 (1.36, 2.51) 2.88 (2.13, 3.89) 1.56 (1.20, 2.02)
 None ref ref ref

Sensory Limitation
 Yes 0.93 (0.72, 1.20) 0.93 (0.71, 1.22) 1.00 (0.76. 1.32)
 No ref ref ref

Depression
 Yes 1.38 (1.20, 1.59) 2.03 (1.76, 2.35) 1.47 (1.28, 1.70)
 No ref ref ref

Anxiety
 Yes 1.04 (0.88, 1.23) 1.70 (1.44, 2.00) 1.63 (1.39, 1.93)
 No ref ref ref

Schizophrenia
 Yes 1.10 (0.60, 2.03) 4.47 (2.71, 7.38) 4.05 (2.50, 6.56))
 No ref ref ref

Parkinson’s Disease
 Yes 0.86 (0.64, 1.14) 1.08 (0.81, 1.43) 1.26 (0.94, 1.68)
 No ref ref ref

Incontinence
 Yes 0.95 (0.83, 1.09) 1.09 (0.95, 1.26) 1.15 (0.99, 1.33)
 No ref ref ref

Seizure disorder
 Yes 1.05 (0.75, 1.46) 1.53 (1.11, 2.11) 1.46 (1.06, 2.00)*
 No ref ref ref

Hypertension
 Yes 1.78 (1.52, 2.07) 1.86 (1.58, 2.19) 1.05 (0.88, 1.24)
 No ref ref ref

Neuropathic Pain
 Yes 1.29 (1.13, 1.48) 1.37 (1.19, 1.59) 1.06 (0.92. 1.23)
 No ref ref

Enabling Factors

Hospitalization in the last year
 Yes 1.56 (1.36, 1.79) 1.89 (1.64, 2.19) 1.21 (1.05, 1.40)
 No ref ref ref

ED visit in the last year
 Yes 1.40 (1.21, 1.62) 1.76 (1.50, 2.06) 1.26 (1.07, 1.48)
 No ref ref ref

Primary Care visit in the last year
 Yes 1.02 (0.88, 1.18) 1.10 (0.94, 1.28) 1.08 (0.92 (1.26)
 No ref ref ref

Specialist visit in the last year
 Yes 1.19 (1.03, 1.38)* 1.43 (1.22, 1.67) 1.20 (1.02, (1.41)*
 No ref ref ref

Geographic region overall * overall *
 Northeast 1.35 (1.11, 1.65) 1.26 (1.02, 1.55)* 0.93 (0.76, 1.14)
 Midwest ref ref ref
 South 1.06 (0.90, 1.25) 1.16 (0.98, 1.38) 1.10 (0.92, 1.31)
 West 1.12 (0.91, 1.38) 0.92 (0.74, 1.16) 0.82 (0.66, 1.04)

Low Income Subsidy/Medicaid Eligibility overall * overall overall
 Neither ref ref ref
 Low income subsidy only 1.26 (1.00, 1.59)* 1.47 (1.15, 1.87) 1.16 (0.92, 1.47)
 Medicaid 1.21 (1.05, 1.40)* 1.61 (1.38, 1.87) 1.33 (1.14, 1.55)
*

p<0.05;

p<0.01;

<0.001

ACB = Anticholinergic Cognitive Burden; OR = Odds Ratio; CCW = Chronic Conditions Warehouse; CPS = Cognitive Performance Scale; AchEI = Acetylcholinesterase Inhibitor; ED = Emergency Department